Camp4 Therapeutics (CAMP) Shares Outstanding (Diluted Average) (2023 - 2026)
Camp4 Therapeutics recorded quarterly Shares Outstanding (Diluted Average) of $57.9 million in Q1 2026, up 90.66% quarter-over-quarter from $30.4 million in Q4 2025, and up 187.42% year-over-year from $20.2 million in Q1 2025.
Camp4 Therapeutics' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $57.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 187.42% year-over-year to $57.9 million; the TTM figure through Mar 2026 stood at $57.9 million (up 187.42% YoY), while the FY2025 annual figure was $30.4 million, up 547.76% from the prior year.
- Shares Outstanding (Diluted Average) came in at $57.9 million for Q1 2026 at Camp4 Therapeutics, up from $30.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.9 million in Q1 2026 to a low of $383653.0 in Q3 2023.
- A 4-year average of $14.8 million and a median of $4.7 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) soared 31.23% in 2024 and jumped 5317.51% in 2025, its largest moves.
- Camp4 Therapeutics' Shares Outstanding (Diluted Average) stood at $394976.0 in 2023, then jumped by 1087.44% to $4.7 million in 2024, then surged by 547.76% to $30.4 million in 2025, then soared by 90.66% to $57.9 million in 2026.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $57.9 million, $30.4 million, and $27.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 57.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.92 Mn |
| Dec 31, 2025 | 30.38 Mn |
| Sep 30, 2025 | 27.27 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 20.15 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 503,455.00 |
| Jun 30, 2024 | 483,640.00 |
| Mar 31, 2024 | 468,695.00 |
| Dec 31, 2023 | 394,976.00 |
| Sep 30, 2023 | 383,653.00 |